Stock markets prove a poor Petri dish for fertility companies
Listed companies in the sector perform poorly despite more people accessing treatment
Related reading
It’s stag season in the IPO markets, but don’t get too close
Buying and flipping shares in primary issues is proving fruitful but companies should prefer less-fickle investors
Looming listings put ailing European IPO market to test
Bankers and lawyers cautiously optimistic that investor confidence is returning
There is method in the market’s madness
But it relies on a host of rosy assumptions going in investors’ favour
Investors need to rethink the ‘factor’ approach
Portfolio management should be based more on themes such as innovation
Of course, there are more ETFs than individual stocks
A multitude of choice might not necessarily be a good thing for investors
European IPO markets show signs of revival
Recent string of listings offers hope after prolonged slowdown